최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생약학회지, v.52 no.3, 2021년, pp.127 - 133
박창은 (남서울대학교 임상병리학과.분자진단연구소) , 이동하 (남서울대학교 임상병리학과.분자진단연구소)
Platelet activation plays a major role in cardiovascular disorders (CVDs). Thus, disrupting platelet activation represents an attractive therapeutic target on CVDs. Esculetin, a bioactive 6,7-dihydroxy derivative of coumarin, possesses pharmacological activities against obesity, diabetes, renal fail...
Jackson, S. P. (2011) Arterial thrombosis-insidious, unpredictable and deadly. Nat. Med. 17: 1423-1436.
Morello, F., Perino, A. and Hirsch, E. (2009) Phosphoinositide 3-kinase esculetin in the vascular system. Cardiovasc. Res. 82: 261-271.
Jennings, L. K. (2009) Role of platelets in atherothrombosis. Am. J. Cardiol. 103: 4A-10A.
Sabatine, M. S. and Jang, I. K. (2000) The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am. J. Med. 109: 224-237.
Cattanco, M., Tenconi, P. M., Lecchi, A. and Mannucci, P. M. (1991) In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb. Res. 62: 717-724.
Su, C. Y., Shiao, M. S. and Wang, C. T. (1999) Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets. Biochem. Pharmacol. 58: 587-595.
Adam, F., Kauskot, A., Nurden, P., Sulpice, E., Hoylaerts, M. F. and Davis, R. J. (2010) Platelet JNK1 is involved in secretion and thrombus formation. Blood 115: 4083-4092.
Bugaud, F., Nadal-Wollbold, F., Levy-Toledano, S., Rosa, J. P. and Bryckaert, M. (1999) Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 94: 3800-3805.
Kramer, R. M., Roberts, E. F., Strifler, B. A. and Johnstone, E. M. (1995) Thrombin induces activation of p38 MAP kinase in human platelets. J. Biol. Chem. 270: 27395-27398.
Nadal-Wollbold, F., Pawlowski, M., Levy-Toledano, S., Berrou, E., Rosa, J. P. and Bryckaert, M. (2002) Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett. 531: 475-482.
Patrono, C. (1994) Aspirin as an antiplatelet drug. N. Engl. J. Med. 330: 1287-1294.
Flevaris, P., Li, Z., Zhang, G., Zheng, Y., Liu, J. and Du, X. (2009) Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood 113: 893-901.
Kramer, R. M., Roberts, E. F., Um, S. L., Borsch-Haubold, A. G., Watson, S. P. and Fisher, M. J. (1996) p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem. 271: 27723-27729.
McNicol, A. and Shibou, T. S. (1998) Translocation and phosphorylation of cytosolic phospholipase A2 in activated platelets. Thromb. Res. 92: 19-26.
Chuang, W. Y., Kung, P. H., Kuo, C. Y. and Wu, C. C. (2013) Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway. Thromb. Haemost. 109: 1120-1130.
Karthika, P., Rajadurai, M., Ganapathy, P. and Kanchana, G. (2012) Preventive effect of esculetin on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in Wistar rats. J. Pharm. Res. 5: 915-918.
Liang, C., Ju, W., Pei, S., Tang, Y. and Xiao, Y. (2017) Pharmacological activities and synthesis of esculetin and its derivatives: A mini-review. Molecules 22: 387.
Hsia, C. W., Lin, K. C., Lee, T. Y., Hsia, C. H., Chou, D. S., Jayakumar, T., Velusamy, M., Chang, C. C. and Sheu, J. R. (2019) Esculetin, a coumarin derivative, prevents thrombosis: inhibitory signaling on PLCγ2-PKC-AKT activation in human platelets. Int. J. Mol. Sci. 20: 2731.
Irfan, M., Jeong, D., Saba, E., Kwon, H. W., Shin, J. H., Jeon, B. R., Kim, S., Kim, S. D., Lee, D. H., Nah, S. Y. and Rhee, M. H. (2019) Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling. Platelets. 30: 589-598.
McNicol, A. and Jackson, E. C. (2003) Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem. Pharmacol. 65: 1243-1250.
Chang, M. C., Wang, T. M., Yeung, S. Y., Jeng, P. Y., Liao, C. H., Lin, C. C., Lin B. R. and Jeng J. H. (2011) Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. Atherosclerosis 219: 559-565.
Cipollone, F., Patrignani, P., Greco, A., Panara, M. R., Padovano, R., Cuccurullo, F., Patrono, C., Rebuzzi, A. G., Liuzzo, G., Quaranta, G. and Maseri, A. (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 96: 1109-1116.
Patrono, C. (2001) Aspirin: new cardiovascular uses for an old drug. Am. J. Med. 110: 62S-65S.
Calderwood, D. A. (2004) Integrin activation. J. Cell. Sci. 117: 657-666.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.